{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 47,
        "end": 56
      }
    },
    {
      "id": "T3",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 132,
        "end": 138
      }
    },
    {
      "id": "T4",
      "obj": "Disease",
      "span": {
        "begin": 204,
        "end": 217
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "23570465_7",
  "text": "RESULTS _ CONCLUSION : In patients adherent to tamoxifen for at least one year ( n = 313 ) there was an association between reduced CYP2D6 activity ( < = 50 % of normal ) and recurrence ( p = 0.025 ) and breast cancer -specific mortality ( p = 0.034 ) ."
}
